Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018

Aydin, Sibel; Robson, Joanna; Sreih, Antoine; Hill, Catherine; Alibaz-Oner, Fatma; Mackie, Sarah; Beard, Susan; Gül, Ahmet; HATEMİ, Gülen; Kermani, Tanaz; Mahr, Alfred; Meara, Alexa; Milman, Nataliya; Shea, Beverley; Tomasson, Gunnar; Tugwell, Peter; Direskeneli, Haner; Merkel, Peter

doi:10.3899/jrheum.181072

Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018

Aydin S. Z., Robson J. C., Sreih A. G., Hill C., Alibaz-Oner F., Mackie S., ...More

JOURNAL OF RHEUMATOLOGY, vol.46, no.9, pp.1198-1201, 2019 (SCI-Expanded)

Publication Type: Article / Article
Volume: 46 Issue: 9
Publication Date: 2019
Doi Number: 10.3899/jrheum.181072
Journal Name: JOURNAL OF RHEUMATOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1198-1201
Keywords: VASCULITIS, TAKAYASU ARTERITIS, GIANT CELL ARTERITIS, LARGE-VESSEL VASCULITIS, OUTCOMES, OMERACT, QUALITY-OF-LIFE, GIANT-CELL ARTERITIS, DISEASE-ACTIVITY, TAKAYASUS-ARTERITIS, ACTIVITY SCORE, HEALTH
Istanbul University Affiliated: Yes

Abstract

Objective. The Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group seeks to develop validated outcome measures for use in trials for large-vessel vasculitis (LVV).